多中心网状组织细胞增生症在18F-FDG PET/CT上模拟恶性肿瘤
本文报告一例75岁女性,因评估尿路上皮癌复发行18F-FDG PET/CT,显示肌肉和淋巴结FDG摄取增高,模拟复发,但多关节和皮下组织亦有FDG摄取,为复发不常见表现。追问病史得知皮肤活检病理诊断为多中心网状组织细胞增生症(MRH),PET/CT表现与MRH一致,MRH是一种病因不明的罕见系统性炎症性肉芽肿病。
要点
- MRH可表现为肌肉、淋巴结、多关节和皮下组织FDG摄取增高,模拟恶性肿瘤复发。
- 当PET/CT出现多关节和皮下组织FDG摄取时,应考虑到MRH等系统性炎症性疾病。
- 结合病史和病理诊断有助于鉴别MRH与恶性肿瘤。
核心结论
- 熟悉MRH特征性18F-FDG PET/CT表现有助于将MRH与恶性肿瘤鉴别。
研究设计与样本
- 本文为病例报告,报告一例75岁女性因评估尿路上皮癌复发行18F-FDG PET/CT。
主要发现
- PET/CT显示FDG摄取的肌肉和淋巴结,模拟复发;多关节和皮下组织亦见FDG摄取,为复发不常见表现。
- 追问病史得知皮肤活检病理诊断为多中心网状组织细胞增生症(MRH),PET/CT表现与MRH一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the case of a 75-year-old woman who underwent F-FDG PET/CT to evaluate the recurrence of urothelial carcinoma. PET/CT showed F-FDG-avid muscles and lymph nodes, mimicking recurrence. However, F-FDG uptake was also seen in multiple joints and subcutaneous tissue, representing an uncommon finding for recurrence. Further history taking revealed she had been pathologically diagnosed with multicentric reticulohistiocytosis (MRH) from skin biopsy, and the F-FDG PET/CT findings were consistent with MRH, a rare systemic inflammatory granulomatous disease of unknown etiology. Knowledge of the characteristic F-FDG PET/CT features of MRH is important to differentiate MRH from malignancy.
引用
- Hotta M, Minamimoto R, Suzuki D, et al. Multicentric Reticulohistiocytosis Mimicking Malignancy on 18F-FDG PET/CT. Clin Nucl Med. 2017. PMID: 28368895. doi:10.1097/RLU.0000000000001661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。